ArticleFrontiers in drug safety and regulation2023

Signal management and risk minimization strategy: a case study on obinutuzumab and non-overt disseminated intravascular coagulation.

Giulia Valdiserra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.